Proactive pharmaceutical care interventions decrease patients’ nonadherence to osteoporosis medication

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Osteoporosis International

• Publication date

  2014-02-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00198-014-2659-8PMID 24570297
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improving Adherence to Lipid-Lowering Therapy in a Community Pharmacy Intervention Program: A Cost-Effectiveness Analysis

  2014cited by this paper
• Persistence with osteoporosis medication among newly-treated osteoporotic patients

  2013cited by this paper
• The population-based prescription database IADB.nl: its development, usefulness in outcomes research and challenges

  2013cited by this paper
• Proactive Pharmaceutical Care Interventions Improve Patients’ Adherence to Lipid-Lowering Medication

  2013cited by this paper
• NHG-Standaard Fractuurpreventie (tweede herziening)

  2012cited by this paper
• Oefenen ter preventie van fracturen

  2012cited by this paper
• Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis

  2012cited by this paper
• Compliance, persistence, and switching patterns for ACE inhibitors and ARBs.

  2011cited by this paper
• Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women

  2011cited by this paper
• The societal burden of poor persistence to treatment of osteoporosis in Sweden.

  2011cited by this paper
• The impact of pharmacist interventions on osteoporosis management: a systematic review

  2011cited by this paper
• Potential Clinical and Economic Impact of Nonadherence with Osteoporosis Medications.

  2010cited by this paper
• Adherence and profile of non-persistence in patients treated for osteoporosis—a large-scale, long-term retrospective study in The Netherlands

  2010cited by this paper
• Potential Clinical and Economic Impact of Nonadherence with Osteoporosis Medications

  2010cited by this paper
• Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis

  2010cited by this paper
• Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial

  2010cited by this paper
• Comparing Adherence and Persistence Across 6 Chronic Medication Classes

  2009cited by this paper
• The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients.

  2009cited by this paper
• Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review

  2009cited by this paper
• Patient responses to an integrated service, initiated by community pharmacists, for the prevention of osteoporosis

  2008cited by this paper
• Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study

  2006cited by this paper
• Quality of life in patients with osteoporosis

  2005cited by this paper
• An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis.

  2005cited by this paper

• Knowledge, attitude, and perceived barriers towards pharmaceutical care among graduating pharmacy students in North West, Ethiopia. -a multicenter cross-sectional study

  2025cites this paper
• Does drug dispensing influence patients’ medication knowledge and medication adherence? A systematic review and meta-analysis

  2025cites this paper
• Perceptions des patientes ostéoporotiques vis-à-vis des traitements prescrits : une étude qualitative

  2024cites this paper
• Barriers to pharmaceutical care provision in the community and hospital pharmacies of Motta town, Northwest Ethiopia: a cross-sectional study

  2024cites this paper
• Supporting patients to get the best from their osteoporosis treatment: a rapid realist review of what works, for whom, and in what circumstance

  2022cites this paper
• Non-Adherence to Anti-Osteoporosis Medication: Factors Influencing and Strategies to Overcome It. A Narrative Review

  2022influential citation
• The role of community pharmacists in delivering interventions for osteoporosis: A systematic review.

  2022cites this paper
• Effective Risk Communication and Improving Adherence

  2021cites this paper
• One-year outcomes of an osteoporosis liaison services program initiated within a healthcare system

  2021cites this paper
• Condition still critical: compliance and persistence with osteoporosis medications

  2021cites this paper
• 2019 EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older

  2020cites this paper
• The extent and barriers in providing pharmaceutical care services by community pharmacists in Malaysia: a cross-sectional study

  2020cites this paper
• Use of path modeling to inform a clinical decision support application to encourage osteoporosis medication use.

  2020cites this paper
• Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review

  2020influential citation
• Prevention and management of osteoporotic fractures by non-physician health professionals: a systematic literature review to inform EULAR points to consider

  2020cites this paper
• Clinical outcomes of community pharmacy services: A systematic review and meta-analysis.

  2019cites this paper
• Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteo

  2019cites this paper
• Scope of Outcomes in Trials and Observational Studies of Interventions Targeting Medication Adherence in Rheumatic Conditions: A Systematic Review

  2019cites this paper
• Effectiveness of pharmaceutical care for drug treatment adherence in women with lupus nephritis in Rio de Janeiro, Brazil: a randomized controlled trial

  2019cites this paper
• Exploring the current role and future role of the pharmacists in osteoporosis screening 1 and management in Malaysia

  2018cites this paper
• Evaluation of a Multimodal, Direct‐to‐Patient Educational Intervention Targeting Barriers to Osteoporosis Care: A Randomized Clinical Trial

  2018cites this paper
• A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates

  2018cites this paper
• Exploring the current and future role of the pharmacists in osteoporosis screening and management in Malaysia

  2018cites this paper
• Pharmaceutical care in Italy and other European countries: between care and commerce?

  2018cites this paper
• Improving drug adherence in osteoporosis: an update on more recent studies

  2018cites this paper
• The role of community pharmacists in disease prevention: A study of the delivery of clinical pharmacy services in community pharmacy in Ireland

  2018cites this paper
• PHARMACEUTICAL CARE AS A CHANCE OF IMPROVING HEALTH CARE IN AREAS WITH AN AVERAGE LEVEL OF URBANIZATION

  2017cites this paper
• Evaluation of an Outpatient Pharmacy Clinical Services Program on Adherence and Fractures among Patients with Osteoporosis

  2017cites this paper
• Review of community pharmacy services: what is being performed, and where are the opportunities for improvement?

  2017cites this paper
• Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands

  2017cites this paper
• Use of a national database as a tool to identify primary medication non‐adherence: The Estonian ePrescription system

  2017cites this paper
• Patient-reported reasons for nonadherence to recommended osteoporosis pharmacotherapy.

  2017cites this paper
• Drug-related problems in patients with osteoporosis Problemi u vezi sa lekovima kod bolesnika sa osteoporozom

  2016cites this paper
• communication during counseling sessions about inhaled corticosteroids at the community pharmacy

  2016cites this paper
• Patients at increased fracture risk: identification and pharmacological treatment

  2016cites this paper
• Addressing the needs of Malaysian postmenopausal women : a pharmacist-led osteoporosis screening programme in a teaching hospital primary-care clinic

  2016cites this paper
• Communication during counseling sessions about inhaled corticosteroids at the community pharmacy

  2016cites this paper
• Effects of targeting disease and medication management interventions towards patients with COPD

  2016cites this paper
• A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention material

  2016cites this paper
• A qualitative study of community pharmacists’ opinions on the provision of osteoporosis disease state management services in Malaysia

  2016cites this paper
• Drug-related problems in patients with osteoporosis.

  2016cites this paper
• A terápiamenedzsment-programok létjogosultsága, eredményessége és gazdaságossága = Rationale, Effectiveness and Economy of Therapy Management Programmes

  2016cites this paper
• Use of pharmacy dispensing data to measure adherence and identify nonadherence with oral hypoglycemic agents

  2016cites this paper
• Adherence to denosumab in the treatment of osteoporosis and its utilization in the Czech Republic

  2015cites this paper
• Long-term persistence with anti-osteoporosis drugs after fracture

  2015cites this paper
• Persistence with denosumab therapy among osteoporotic women in the Canadian patient-support program

  2015cites this paper
• Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands

  2015cites this paper
• Higher Adherence During Reimbursement of Pharmacological Smoking Cessation Treatments.

  2015cites this paper
• Role of the Pharmacist in Medication Therapy Management Services in Patients With Osteoporosis.

  2015cites this paper
• interventional tools to improve medication adherence: review of literature

  2015cites this paper
• interventional tools to improve medication adherence: review of literature

  2015cites this paper
• interventional tools to improve medication adherence: review of literature

  2015cites this paper
• Interventional tools to improve medication adherence: review of literature

  2015cites this paper
• Medication Monitoring and Optimization: A Targeted Pharmacist Program for Effective and Cost-Effective Improvement of Chronic Therapy Adherence

  2014cites this paper
• Impacto do seguimento farmacoterapêutico sobre a adesão e a qualidade de vida de mulheres com neoplasia de mama em tratamento com tamoxifeno

  2014cites this paper